Table 1. Association of serum miR-17 and miR-106b levels with clinicopathological features of GC patients.

Clinicopathological characteristics	N	P
		miR-17	miR-106b
Gender		0.666	0.896
Male	28
Female	12
Age (years)		0.02	0.017
>53	26
≤53	14
Tumor differentiation		0.857	0.847
Well	10
Poor	30
TNM stage		0.602	0.402
Early (I/II)	9
Later (III/IV)	31
Lymph node metastasis		0.97	0.83
Yes	28
No	12

GC, gastric cancer.